LON/0LO3 (LON/0LO3)

London Stock Exchange: LON/0LO3 · USD

$315

+2.35 (+0.8%)· Recorded snapshot

Market cap	38.5B
Revenue (ttm)	2.6B
Net income (ttm)	753.9M
EPS (ttm)	$4.59
P/E (trailing)	51.7x
P/E (forward)	31.8x
Volume	1,916
Beta	0.93

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.6B
Net income (ttm): 753.9M
EPS (ttm): $4.59
P/E (trailing): 51.7x
P/E (forward): 31.8x
Market cap: 38.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E31.8

P25 n/aP50 n/aP75 n/a

Trailing P/E51.7

P25 n/aP50 n/aP75 n/a

ROE14.4

P25 n/aP50 n/aP75 n/a

ROIC95.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LON/0LO3 indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-12-02
Employees	7,928
Employees change	119
Employees growth	1.66%
Enterprise value	$33.2B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-10
Fiscal year end	January
Founded	2007
Industry	Health Information Services
Is primary listing	No
ISIN number	US9224751084
Last earnings date	2026-08-26
Last refreshed	2026-10-28
Market cap	$38.5B
Next earnings date	2026-12-02
Price	$315.14
Price currency	USD
Sector	Healthcare
SIC code	7370
Stock price date	2026-10-28
Symbol	lon/0LO3
Website	https://www.veeva.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	71x
Average P/E ratio (3Y)	48.61x
Average P/E ratio (5Y)	58.65x
Earnings yield	1.94%
EV/Earnings	43.52x
EV/EBIT	42.19x
EV/EBITDA	39.86x
EV/FCF	26.95x
EV/Sales	12.63x
FCF / EV yield	3.71%
FCF yield	3.19%
Forward P/E	31.82x
Graham number	79.4068
Graham upside	-74.63%
Lynch fair value	$117.86
Lynch upside	-62.34%
P/(FCF - SBC) ratio	44.87x
P/(OCF - SBC) ratio	43.85x
P/B ratio	6.91x
P/E ratio	51.66x
P/FCF ratio	31.33x
P/OCF ratio	30.83x
P/S ratio	14.85x
Price / tangible book value	7.46x
Price/EBITDA ratio	47.74x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	29.93%
EBITDA margin	31.1%
Effective tax rate	23.55%
FCF margin	46.74%
Gross margin	74.96%
Operating margin	29.93%
Pretax margin	38.38%
Profit margin	29.34%
Profit per employee	$95,088
Profitable quarters	56
Profitable years	16
Revenue per employee	$324,035
ROA	7.58%
ROA (5Y)	6.94%
ROCE	13.61%
ROE	14.42%
ROE (5Y)	14.27%
ROIC	95.58%
ROIC (5Y)	72.98%
SBC / revenue	14.3%
Tax / revenue	9.04%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	25.52%
EPS growth (Q)	39.5%
EPS growth (QoQ)	5.73%
EPS growth 10Y	32.35%
EPS growth 3Y	22.48%
EPS growth 5Y	18.41%
EPS growth quarters	10
EPS growth years	15
FCF growth	23.4%
FCF growth (Q)	-0.62%
FCF growth (QoQ)	-79.5%
FCF growth 3Y	19.72%
FCF growth 5Y	16.93%
Gross profit growth	15.53%
Gross profit growth (Q)	17.2%
Gross profit growth 3Y	17.98%
Gross profit growth 5Y	16.49%
Net income growth	25.29%
Net income growth (Q)	36.5%
Net income growth (QoQ)	4.79%
Net income growth 3Y	23.39%
Net income growth 5Y	19.05%
Net income growth quarters	10
Net income growth years	15
OCF growth	23.44%
OCF growth (Q)	0.12%
OCF growth (QoQ)	-78.82%
OCF growth 10Y	27.71%
OCF growth 3Y	19.46%
OCF growth 5Y	16.95%
Operating income growth	24.68%
Operating income growth (Q)	21.4%
Operating income growth 3Y	37.75%
Operating income growth 5Y	17.95%
Revenue growth	16.5%
Revenue growth (Q)	17.6%
Revenue growth (QoQ)	5.1%
Revenue growth 10Y	22.03%
Revenue growth 3Y	15.71%
Revenue growth 5Y	15.76%
Revenue growth quarters	52
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-19.8M
Depreciation and amortization	$30.5M
EBIT	$768.8M
EBITDA	$798.8M
EPS	$4.59
Financing cash flow	$-495.7M
Free cash flow	$1.2B
Free cash flow minus SBC	$850M
Gross profit	$1.9B
Income taxes	$232.2M
Investing cash flow	$-828.5M
Net cash flow	$-87.9M
Net income	$753.9M
Operating cash flow minus SBC	$869.8M
Operating income	$768.8M
Revenue	$2.6B
Stock-based compensation	$367.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	15.64
Book value per share	$34.11
Debt / EBITDA	0.14
Debt / equity	0.02
Debt / FCF	0.09
Goodwill	$371.3M
Long-term assets	$745.8M
Long-term liabilities	$113.4M
Net cash (debt)	$5.3B
Net cash / market cap	13.81%
Net cash growth	12.23%
Net debt / EBITDA	-6.59
Net debt / equity	-0.95
Net debt / FCF	-4.33
Piotroski F-Score	4
Property, plant and equipment	$157.3M
Shareholders' equity	$5.5B
Tangible book value	$5.1B
Tangible book value per share	$31.59
Total assets	$6.7B
Total cash	$5.4B
Total debt	$112.7M
Total liabilities	$1.2B
WACC	9.36%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.41
Current assets	$6B
Current liabilities	$1.1B
Current ratio	5.46
Net working capital	$-548.3M
Quick ratio	5.36
Working capital	$4.8B
Working capital turnover	0.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.14%
Shareholder yield	0.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$213.56
1D price change	0.75%
1M price change	12.4%
1M total return	12.4%
1W price change	0.27%
1W total return	0.27%
1Y price change	6.55%
1Y return CAGR	6.55%
1Y total return	6.55%
20-day SMA	$301.90
200-day SMA	$208.45
3M price change	59.69%
3M total return	59.69%
3Y price change	64.5%
3Y return CAGR	18.04%
3Y total return	64.5%
50-day SMA	$281.44
50-day SMA vs 200-day SMA	50over200
52-week high	$330.00
52-week high date	2026-10-26
52-week low	$148.70
52-week low date	2026-04-10
5Y price change	-0.49%
5Y return CAGR	-0.1%
5Y total return	-0.49%
6M price change	95.17%
6M total return	95.17%
All-time high	$343.22
All-time high date	2021-08-05
All-time low	$54.32
All-time low date	2018-02-09
Average true range (ATR)	$13.80
Average volume	1.2K
Beta (5Y)	0.93
Change from 52-week high	-4.5%
Change from 52-week low	111.93%
Change from all-time high	-8.18%
Change from all-time low	480.15%
Change from open	0.28%
Day's gap	0.47%
Dollar volume	$603,808
High price	$319.16
Low price	$302.59
Monthly RSI	65.02
Open price	$314.25
Position in 52-week range	75.74%
Previous close	$312.79
Price vs 150-day SMA	47.56%
Price vs 20-day SMA	4.38%
Price vs 200-day SMA	51.18%
Price vs 50-day SMA	11.97%
Relative volume	1.65
RSI	62.98
Sharpe ratio	0.28
Sharpe ratio (3Y)	0.45
Sharpe ratio (5Y)	0.13
Sortino ratio	0.57
Sortino ratio (3Y)	0.86
Sortino ratio (5Y)	0.34
Volume	1.9K
Weekly RSI	70.97
YTD price change	40.09%
YTD total return	40.09%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	148.3M
Shares change (QoQ)	-0.56%
Shares change (YoY)	-0.14%
Shares held by insiders	8.32%
Shares held by institutions	90.54%
Short ratio	2.5 days

Deeper analysis on LON/0LO3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LON/0LO3 report

Is a complete LON/0LO3 research report available?

No complete published report is available for lon/0LO3 (LON/0LO3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0LO3 (LON/0LO3)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0LO3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0LO3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0LO3

Frequently asked questions